We use cookies to give you the best possible experience on our website.

The challenges we face

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

a fully funded intensive support programme for life science SMEs working in Greater Manchester

How can the Innovation Nexus help me?

Speak directly to a GM AHSN advisor with NHS expertise

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations

Connect you with relevant organisations

 

Free industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus can give you access a network of specialist advice and support.

Subscribe to our mailing list

* indicates required

Asset Publisher Asset Publisher

Back

Early Diagnosis Industry Challenge - 22 February to 30 March 2017

The national Cancer Vanguard recently launched a unique and innovative opportunity for a select group of industry, academic or third sector partners to work on a project improving the early diagnosis of cancer.

Dr Linda Magee, GM AHSN’s Executive Director for Industry & Wealth, and Richard Deed, Technology Director at TRUSTECH will be assessing applications for the call, which launched 22 February and closes at 16.00 on March 30.

The aim of this challenge is to engage expertise from outside the NHS to undertake a small number of high impact projects (five to eight) which will ultimately lead to a tangible improvement in the earlier diagnosis of cancer in the NHS. There is a specific focus on two outcomes:

  1. Increasing the proportion of cancers detected at stage 1 & 2 (stage shifts)
  2. Reducing the proportion of cancers detected through presentation at A&E

The Industry Challenge team is looking for a wide range of early diagnosis projects, which would benefit from access to the national Cancer Vanguard’s knowledge and resources. Projects should launch from May 2017 and conclude by end April 2018.

The Cancer Vanguard will be holding an information event from 15:00-17:00 on 16 March, at 52 Club, Bonham Carter House, 52 Gower St, London WC1E 6EB. If you would like to attend, please register by emailing CancerVanguard@uclh.nhs.uk

The application forms and FAQs document are available to download below. If you have any questions about the call which are not answered in the FAQs, please contact CancerVanguard@uclh.nhs.uk 

Download FAQs here.

Download application form A application form B here.

Find out more about the Cancer Vanguard here.

Find out about the GM Cancer Vanguard.